The cost of immunotherapy with Keytruda (pembrolizumab) in Spain generally runs from $15,000 to $25,000. Pricing depends on factors such as the number of treatment cycles, the patient’s diagnosis, and the hospital’s location. In the United States, the average cost is $21,500 (per NCCN guidelines). This means immunotherapy with Keytruda in Spain is typically about _price_percent_discount_% less than in the U.S.
Spanish hospitals usually include the drug itself, oncologist consultations, infusion sessions, and routine monitoring in the price. In the U.S., medication, administration, and follow-up visits are often billed separately. Always confirm what’s included with each clinic or hospital before starting treatment.